DOES CISATRACURIUM AT A CLINICAL DOSE ATTENUATE THE IMMUNOSUPPRESSION AFTER SURGERY IN SMOKING PATIENTS WITH NON-SMALL CELL LUNG CANCER?

Sun, Wen-qin

DOES CISATRACURIUM AT A CLINICAL DOSE ATTENUATE THE IMMUNOSUPPRESSION AFTER SURGERY IN SMOKING PATIENTS WITH NON-SMALL CELL LUNG CANCER? [electronic resource] - Middle East journal of anaesthesiology Oct 2015 - 375-7 p. digital

Publication Type: Letter

0544-0440


Atracurium--administration & dosage
Carcinoma, Non-Small-Cell Lung--pathology
Humans
Immunocompromised Host--drug effects
Lung Neoplasms--pathology
Neuromuscular Blocking Agents--administration & dosage
Postoperative Complications--immunology
Smoking--adverse effects
Stress, Physiological--immunology